Trump Action Archive

Supporting reports

• Trump signs executive order realigning U.S. childhood vaccine schedule with peer nations' recommendations — President Trump signed Executive Order 14407 directing the CDC and its Advisory Committee on Immunization Practices to review a scientific assessment comparing U.S. childhood immunization recommendations with peer developed nations and update the vaccine schedule accordingly. The order acknowledges that the U.S. currently recommends more childhood vaccines than peer nations and directs federal agencies to align immunization policies with the updated schedule while preserving parental authority and religious freedom protections. All vaccines on the revised schedule remain covered without cost-sharing by insurance and public programs.
• Trump executive order directs CDC to halve childhood vaccine recommendations — Donald Trump signed an executive order on May 29, 2026, instructing the Centers for Disease Control and Prevention to reduce the number of recommended childhood vaccines by nearly half, based on a health department assessment authored by anti-vaccine activist Robert F. Kennedy Jr.'s HHS. The order would remove vaccines for hepatitis A, hepatitis B, meningitis, rotavirus, influenza, and COVID-19 from the recommended schedule, and cut HPV vaccine doses. Fifteen Democratic-led states have sued to block the changes, arguing they lack scientific basis and will increase disease outbreaks and childhood illness.
• Trump issues executive order realigning U.S. childhood vaccine schedule with peer nations' recommendations — President Trump issued an executive order on May 29, 2026, directing the Department of Health and Human Services to realign U.S. childhood vaccine recommendations with those of peer developed nations. The order cites a scientific assessment finding that the U.S. recommends more childhood vaccines than comparable countries and directs the CDC and its Advisory Committee on Immunization Practices to review and update the vaccine schedule accordingly. The order emphasizes parental authority, religious freedom protections, and maintaining vaccine access through insurance and public programs while reducing the number of recommended doses.
• White House issues fact sheet on executive order realigning childhood vaccine schedule — The White House published a fact sheet on May 29, 2026, describing an executive order signed by President Trump directing the CDC and its Advisory Committee on Immunization Practices (ACIP) to review an HHS scientific assessment comparing U.S. childhood vaccine recommendations with those of peer developed nations. The order directs ACIP to update the U.S. childhood vaccine schedule based on this review, emphasizing flexibility for parents and doctors. The fact sheet states the assessment found the U.S. recommends more childhood vaccines than peer nations and recommends prioritizing 11 routine vaccines while preserving individualized decision-making.
• White House signed executive order realigning U.S. childhood vaccine schedule with peer nations' recommendations — The White House signed Executive Order 14407 directing the CDC and its Advisory Committee on Immunization Practices to review and update the U.S. childhood vaccine schedule based on a scientific assessment comparing American recommendations with those of peer developed nations. The order states the assessment found the U.S. recommends more childhood vaccines than peer countries, including twice as many doses as some European nations, and identifies a consensus set of vaccines recommended across all peer countries. The order directs federal agencies to align immunization policies, funding, and coverage with the updated CDC schedule while preserving parental authority and religious freedom protections.

Supporting reports

• OMB proposes rule placing federal research grants under political appointee control — On May 29, 2026, OMB Director Russ Vought proposed a rule that would place all federal research and discretionary grants under the control of political appointees rather than scientific experts. The rule would prohibit grants that "promote anti-American values" and require awards to "demonstrably advance the president's policy priorities." Stand Up for Science estimates nearly half of approximately 10,000 NIH-funded clinical trials could be discontinued, including over 1,000 cancer trials, pediatric studies, and trials addressing veterans' health, suicide, heart disease, and diabetes. The public comment period closes July 13, 2026.
• Trump administration proposed merit-based federal research grant system be replaced with political appointee approval — On May 29, 2026, the Trump administration proposed dramatic changes to federal research grant awards. Rather than continuing the merit-based system established through rigorous peer review, grants would be awarded based on approval by political appointees. The Office of Management and Budget, directed by Christian nationalist Russell Vought, would control grant allocation. The proposal limits foreign collaboration and allows the OMB to revoke grants deemed to fail "program goals, Federal agency priorities, or the national interest."
• Russell Vought proposes political control over research grants — Russell Vought, director of the Office of Management and Budget and co-author of Project 2025, proposed on May 28 that political appointees in his office should have final say over research grants, including those for the National Institutes of Health, the National Science Foundation, and other governmental science agencies. The proposal aims to root out what it characterizes as a "woke" policy agenda and would also require approval by political appointees for international research collaboration.

Supporting reports

• FDA sends serious enforcement letter to pharmaceutical company; CEO donates $1 million to Trump super PAC days later — On May 26, the FDA sent a letter to pharmaceutical company QOL Medical containing serious allegations that could threaten the company's existence. Days later, QOL Medical CEO Frederick Cooper donated $1 million to MAGA Inc., Trump's super PAC. The timing and sequence raise questions about whether the donation was made in response to the regulatory threat or as an attempt to influence the agency's enforcement action.
• FDA sends warning letter to QOL Medical for false drug advertising — On May 26, 2026, the FDA sent a warning letter to QOL Medical accusing the pharmaceutical company of using "false or misleading" advertising to promote Sucraid, a drug for treating congenital sucrase-isomaltase deficiency (CSID). The FDA alleged that QOL Medical's marketing materials encouraged doctors to prescribe Sucraid for patients with IBS-like symptoms (gas, bloating, diarrhea, nausea), despite the drug being unable to treat IBS or its symptoms. The FDA determined QOL Medical violated the Federal Food, Drug, and Cosmetic Act's prohibition on drug misbranding. The letter required QOL Medical to respond within 15 working days.